Published August 28, 2010 | Version 10429

Some Peculiarities of Growth and Functional Activity of Escherichia coli Strain from Probiotic Formula "ASAP"

Description

It has been shown that pH 7,3 and 37 0C are the optimal condition for the growth of E. coli “ASAP". The cells grow well on Glucose, Lactose, D-Mannitol, D-Sorbitol, (+)-Xylose, L- (+)-Arabinose and Dulcitol. No growth has been observed on Sucrose, Inositol, Phenylalanine, and Tryptophan. The strain is sensitive to a range of antibiotics. The present study has demonstrated that E. coli “ASAP" inhibit the growth of S. enterica ATCC #700931 in vitro. The studies on conjugating activity has revealed no conjugant of E. coli “ASAP" with plasmid strains E. coli G35#59 and S. enterica ATCC #700931. On the other hand, the conjugants with low frequencies were obtained from E. coli “ASAP" with E. coli G35#61, and E. coli “ASAP" with randomly chosen isolate from healthy human gut microflora: E. coli E6. The results of present study have demonstrated improvements in gut microflora condition of patients with different diseases after the administration of “ASAP"

Files

10429.pdf

Files (385.8 kB)

Name Size
md5:42ed52606f3e1213a0fd696e7329fd6e
385.8 kB Preview Download

Additional details

References

  • M. Wilson, "Microbial inhabitants of humans. Their ecology and role in health and disease", In: Cambridge University Press. Cambridge. United Kingdom, 2005.
  • A. Pepoyan and A. Trchounian, "Biophysics, molecular and cellular biology of probiotic activity by bacteria", In: Bacterial Membranes. Ultrastructure, Bioelectrochemistry, Biophysics and Bioenergetics. Ed. A. Trchounian. Kerala (India): Research Signpost, 2009.
  • E. Cario, Curr Opin Gastroenterol, 2008, vol. 24, pp. 725-732.
  • S.Doron, S.L. Gorbach, Expert Rev. Anti-infective, 2006, vol. 4, no. 2, pp. 261-275.
  • M. Schultz, A.L. Lindström, Expert Rev. Gastroenterol. Hepatol, 2008, vol. 2, pp. 337-355.
  • Marteau P., Seksik P., Jian R, Br. J. Nutr, 2002, vol. 88. (suppl 1): pp. 51-57.
  • H.S. Gill, G. F. Postgrad, Med. J, 2004, vol. 80, pp. 516-526.
  • I Wollowski, G Rechkemmer, BL Pool-Zobel, Am. J. Clin. Nutr, 2001, vol. 73, pp. 451-455.
  • Y. Aso, H.Akazan, T. Kotake, T. Tsukamoto, K. Imai, S. Naito, Eur. Urology, 1995, vol. 27, pp. 104-109. [10] D. Haller, S. Blum, C. Bode, W.P. Hammes, E.J. Schiffrin, Infection and Immunity, 2000, vol. 68, pp. 752-759. [11] B. Corthesy, H.R. Gaskins, A. Mercenier, J. Nutr. 2007, vol. 137, pp. 781-790. [12] K.Madsen, A.Cornish, P.Soper, C.McKaigney, H.Jijon, C.Yachimec, J.Doyle, L. Jewell, C.De Simone, Gastroenterology, 2001, vol. 121, pp. 580-591. [13] G.W. Elmer, Am. J. Health Syst. Pharm, 2001, vol. 58, pp. 1101-1109. [14] D.Damaskos, G.Kolios, Br. J. Clin. Pharmacol, 2008, vol. 65, no. 4, pp. 453-67. [15] ðÉ.ðù. ðƒðÁð┐ð¥ÐÅð¢, "ð¿Ðéð░ð╝ð╝ ð▒ð░ð║ÐéðÁÐÇð©ð╣ Escherichia coli "ðÉðíðÉðƒ", ð©Ðüð┐ð¥ð╗ÐîðÀÐâðÁð╝Ðïð╣ ð┤ð╗ÐÅ ð┐ð¥ð╗ÐâÐçðÁð¢ð©ÐÅ ð┐ÐÇð¥ð▒ð©ð¥Ðéð©ÐçðÁÐüð║ð¥ð│ð¥ ð┐ÐÇðÁð┐ð░ÐÇð░Ðéð░, ð© ð┐ÐÇð¥ð▒ð©ð¥Ðéð©ÐçðÁÐüð║ð©ð╣ ð┐ÐÇðÁð┐ð░ÐÇð░Ðé ð¢ð░ ð¥Ðüð¢ð¥ð▓ðÁ ÐìÐéð¥ð│ð¥ ÐêÐéð░ð╝ð╝ð░": ð╗ð©ÐåðÁð¢ðÀð©ÐÅ #1834-P20050220, In: ðÉð│ðÁð¢ÐéÐüÐéð▓ð¥ ð©ð¢ÐéðÁð╗ð╗ðÁð║ÐéÐâð░ð╗Ðîð¢ð¥ð╣ Ðüð¥ð▒ÐüÐéð▓ðÁð¢ð¢ð¥ÐüÐéð© ðáðÁÐüð┐Ðâð▒ð╗ð©ð║ð© ðÉÐÇð╝ðÁð¢ð©ÐÅ. ðòÐÇðÁð▓ð░ð¢, 2006. [16] M.L. Marco, S. Pavan, M. Kleerebezem, Curr. Opin. Biotechnol. 2006, vol. 17, no. 2, pp. 204-210. [17] S.I. Patzer, M.R. Baquero, D. Bravo, F. Moreno, K. Hantke, Microbiology, 2003, vol. 149, pp. 2557-2570. [18] M. Valdebenito, A.L. Crumbliss, G. Winkelmann, K. Hantke, Int. J. Med. Microbiol, 2006, vol. 296, pp. 513-520. [19] J. Boudeau, A.L. Glasser, S. Julien, J.F. Colombel, A. Darfeuille- Michaud, Aliment Pharmacol. Ther, 2003, vol. 18, pp. 45-56. [20] A. fer Altenhoe, S. Oswald, U. Sonnenborn, C. Enders, J. Schulze, J. Hacker, T. A. Oelschlaeger, FEMS Immunol. Med. Microbiol, 2004, vol. 40, pp. 223-229. [21] J. Wehkamp, J. Harder, K. Wehkamp, Infection and Immunity. 2004, vol. 72, pp. 5750-5758. [22] S.N. Ukena, A.M. Westendorf, W. Hansen, M. Rohde, R. Geffers, S. Coldewey, S. Suerbaum, J. Buer, F. Gunzer, BMC Med. Genet, 2005, vol. 6, p. 43. [23] A.A. Zyrek, C. Cichon, S. Helms, C. Enders, U. Sonnenborn, M.A. Schmidt, Cell Microbiol, 2007, vol. 9, pp. 804-816. [24] A. Von Wright, Curr. Pharm. Des, 2005, vol. 11, pp. 17-23. [25] D.C. Donohue, Asian Pac. J. Clin. Nutr, 2006, vol. 15, pp. 563-569. [26] ðÜ. ðíÐéðÁð┐ð░ð¢ÐÅð¢, ð£. ðæð░ð╗ð░ÐÅð¢, ðÉ. ðÆð░Ðüð©ð╗ÐÅð¢, ðÉ. ðƒðÁð┐ð¥ÐÅð¢, ðÉ. ðóÐÇÐçÐâð¢ÐÅð¢, ðæð©ð¥ð╗. ð£ðÁð╝ð▒ÐÇð░ð¢Ðï, 2007, vol. 24, pp. 389-394. [27] A. Shahinyan, J. Garibyan, A. Pepoyan, O. Karapetyan, New El. J. Nat. Sci, 2003, vol. 1, pp. 53-58. [28] A. Trchounian, E. Ohanjanyan, K. Bagramyan, E. Zakharyan, V. Vardanian, A. Vassilian, M. Davtian, Biosci. Rep, 1998, vol. 18, pp. 143-154. [29] N. Mirzoyan, A. Pepoyan, A. Trchounian, FEMS Microbiol. Lett, 2006, vol. 254, pp. 81-86. [30] E.S. Lennox, Virology, 1955, vol. 1, p. 190. [31] P.R. Murray, E.J. Baron, M.A. Pfaller, P.C. Tenover, R.H. Yolken, (eds): Manual of Clinical Microbiology. 6th ed., ASM Press, Washington, DC, 1995. [32] N.C. Birnboim, J.A. Doli, Nucl. Acid Res, 1979, vol. 7, pp. 1513-1518. [33] R.M. Reyed, The Internet J. Biol. Anthropol, 2007, vol. 3, No 2. [34] N.M. Clark, J. Patterson, J.P. Lynch, Curr. Opin. Crit. Care, 2003, vol. 9, pp. 413-423. [35] T. Barbosa, S. B. Levy, Drug Resistance Updates, 2000, vol. 3, pp. 303- 311. [36] A.A. Salyers, A. Gupta, Y. Wang, Trends Microbiol, 2004, vol. 12, no. 9, pp. 412-416. [37] D.P. Blake, K. Hillman, D.R. Fenlon, J.C. Low, J. Appl. Microbiol, 2003, vol. 95, no 3, pp. 428-436. [38] H. Kruse, H. Sorum, Appl. Environ. Microbiol, 1994, vol. 60, no. 11, pp. 4015-4021. [39] F. Doucet-Populaire, P. Trieu-Cuot, A. Andremont, P. Courvalin, Antimicrob. Agents Chemother, 1992, vol. 36(2), pp. 502-504. [40] P. Gionchetti, F. Rizzello, K.M. Lammers, C. Morselli, L Sollazzi., S. Davies, R. Tambasco, C. Calabrese, M. Campieri, World J. Gastroenterol, 2006, vol. 12, no. 21, pp. 3306-3313. [41] G.E. Bergonzelli, S. Blum, H. Brussow, I. Corthe'sy-Theulaz, Digestion, 2005, vol. 72, no. 1, pp. 57-68. [42] E.S. Huebner, C.M. Surawicz, Gastroenterol. Clin. North. Am, 2006, vol. 35, pp. 355-365. [43] H.S. Gill, Best Pract. Res. Clin. Gastroenterol, 2003, vol. 17, pp. 755- 773. [44] R. Reissbrodt, W.P. Hammes, F. dal Bello, R. Prager, A. Fruth, K. Hantke, A. Rakin, M. Starcic-Erjavec, P.H. Williams, FEMS Microbiol Lett., 2009, vol. 290, no. 1, pp. 62-69. [45] M. Boirivant, W. Strober, Curr. Opin. Gastroenterol, 2007, vol. 23, no. 6, pp. 679-692. [46] ðØ.ð£. ðôÐÇð░ÐçðÁð▓ð░, ðÆ.ð£. ðæð¥ð¢ð┤ð░ÐÇðÁð¢ð║ð¥, ðÿð¢ÐäðÁð║Ðå. ðæð¥ð╗ðÁðÀð¢ð©, 2004, vol. 2, no. 2, pp. 53-58. [47] ðÆ.ð£. ðæð¥ð¢ð┤ð░ÐÇðÁð¢ð║ð¥, ðÉ.ðÉ. ðÆð¥ÐÇð¥ð▒ÐîðÁð▓, ðûÐâÐÇð¢. ð╝ð©ð║ÐÇð¥ð▒ð©ð¥ð╗., Ðìð┐ð©ð┤ðÁð╝ð©ð¥ð╗. ð©ð╝ð╝Ðâð¢ð¥ð▒ð©ð¥ð╗. 2004, pp. 84-92.